Cargando…
Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021
OBJECTIVES: This study aimed to describe the characteristics and risk factors for severe disease in pregnant women infected with coronavirus disease 2019 (COVID-19) from the early days of the COVID-19 epidemic in Korea to the predominant period of the Delta variant. METHODS: A retrospective cohort s...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Disease Control and Prevention Agency
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211450/ https://www.ncbi.nlm.nih.gov/pubmed/37183333 http://dx.doi.org/10.24171/j.phrp.2023.0025 |
_version_ | 1785047278018363392 |
---|---|
author | Lee, Ji Joo Lee, Sang-Eun Kim, Yeonjung Park, Young-Joon |
author_facet | Lee, Ji Joo Lee, Sang-Eun Kim, Yeonjung Park, Young-Joon |
author_sort | Lee, Ji Joo |
collection | PubMed |
description | OBJECTIVES: This study aimed to describe the characteristics and risk factors for severe disease in pregnant women infected with coronavirus disease 2019 (COVID-19) from the early days of the COVID-19 epidemic in Korea to the predominant period of the Delta variant. METHODS: A retrospective cohort study was conducted among pregnant women diagnosed with COVID-19 between February 2020 and December 2021. Logistic regression analysis was performed to compare severe and mild cases after adjusting for pregnant women’s age, nationality, infection route, outbreak area, infection period, symptoms, underlying disease, smoking status, trimester, and COVID-19 vaccination status. RESULTS: In total, 2,233 pregnant women were diagnosed with COVID-19 by December 2021. Among these, 96.7% had mild symptoms, 3.3% had severe symptoms, and 0.04% died. The risk factors for severe disease in pregnant women with confirmed COVID-19 were being in the age group of 35 to 45 years, having hyperlipidemia, being in the second or third trimester of pregnancy at the time of COVID-19 diagnosis, being infected during the Delta-predominant period, and having a fever (≥38 °C) at diagnosis. Furthermore, 47.1% of patients in the mild group and 84.9% of patients in the severe group had 3 or more risk factors. CONCLUSION: Pregnant women with COVID-19 mainly experienced mild symptoms, but those with risk factors were at a higher risk of developing severe symptoms. Therefore, treatment and follow-up management should be thoroughly implemented. |
format | Online Article Text |
id | pubmed-10211450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Korea Disease Control and Prevention Agency |
record_format | MEDLINE/PubMed |
spelling | pubmed-102114502023-05-26 Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021 Lee, Ji Joo Lee, Sang-Eun Kim, Yeonjung Park, Young-Joon Osong Public Health Res Perspect Original Article OBJECTIVES: This study aimed to describe the characteristics and risk factors for severe disease in pregnant women infected with coronavirus disease 2019 (COVID-19) from the early days of the COVID-19 epidemic in Korea to the predominant period of the Delta variant. METHODS: A retrospective cohort study was conducted among pregnant women diagnosed with COVID-19 between February 2020 and December 2021. Logistic regression analysis was performed to compare severe and mild cases after adjusting for pregnant women’s age, nationality, infection route, outbreak area, infection period, symptoms, underlying disease, smoking status, trimester, and COVID-19 vaccination status. RESULTS: In total, 2,233 pregnant women were diagnosed with COVID-19 by December 2021. Among these, 96.7% had mild symptoms, 3.3% had severe symptoms, and 0.04% died. The risk factors for severe disease in pregnant women with confirmed COVID-19 were being in the age group of 35 to 45 years, having hyperlipidemia, being in the second or third trimester of pregnancy at the time of COVID-19 diagnosis, being infected during the Delta-predominant period, and having a fever (≥38 °C) at diagnosis. Furthermore, 47.1% of patients in the mild group and 84.9% of patients in the severe group had 3 or more risk factors. CONCLUSION: Pregnant women with COVID-19 mainly experienced mild symptoms, but those with risk factors were at a higher risk of developing severe symptoms. Therefore, treatment and follow-up management should be thoroughly implemented. Korea Disease Control and Prevention Agency 2023-04 2023-04-05 /pmc/articles/PMC10211450/ /pubmed/37183333 http://dx.doi.org/10.24171/j.phrp.2023.0025 Text en © 2023 Korea Disease Control and Prevention Agency. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Original Article Lee, Ji Joo Lee, Sang-Eun Kim, Yeonjung Park, Young-Joon Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021 |
title | Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021 |
title_full | Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021 |
title_fullStr | Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021 |
title_full_unstemmed | Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021 |
title_short | Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021 |
title_sort | analysis of pregnant women with critically severe covid-19 in korea from february 2020 and december 2021 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211450/ https://www.ncbi.nlm.nih.gov/pubmed/37183333 http://dx.doi.org/10.24171/j.phrp.2023.0025 |
work_keys_str_mv | AT leejijoo analysisofpregnantwomenwithcriticallyseverecovid19inkoreafromfebruary2020anddecember2021 AT leesangeun analysisofpregnantwomenwithcriticallyseverecovid19inkoreafromfebruary2020anddecember2021 AT kimyeonjung analysisofpregnantwomenwithcriticallyseverecovid19inkoreafromfebruary2020anddecember2021 AT parkyoungjoon analysisofpregnantwomenwithcriticallyseverecovid19inkoreafromfebruary2020anddecember2021 |